# ENABLERS CONSOLIDATION - QUICK REFERENCE

## ğŸ”„ What Changed

### **BEFORE (Original 4 Enabler Categories):**
```
Enablers & Ecosystem (11 personas):
â”œâ”€â”€ Capital Providers (3)
â”‚   â”œâ”€â”€ VC Partner
â”‚   â”œâ”€â”€ Corporate Venture Director
â”‚   â””â”€â”€ Angel Investor
â”œâ”€â”€ Consulting & Advisory (3)
â”‚   â”œâ”€â”€ Strategy Consultant
â”‚   â”œâ”€â”€ Implementation Consultant
â”‚   â””â”€â”€ Change Management
â”œâ”€â”€ Technology Partners (3)
â”‚   â”œâ”€â”€ EHR Integration
â”‚   â”œâ”€â”€ Cloud Platform
â”‚   â””â”€â”€ API/Interop Vendor
â””â”€â”€ Research & Academia (2)
    â”œâ”€â”€ Clinical Research PI
    â””â”€â”€ Health Services Researcher
```

### **AFTER (Consolidated 2 Categories):**
```
Digital Health - EXPANDED (40 personas):
â”œâ”€â”€ DH Startups (37 personas) [existing]
â””â”€â”€ Technology Partners (3) â† MERGED
    â”œâ”€â”€ EHR Integration Partner
    â”œâ”€â”€ Cloud Platform Provider
    â””â”€â”€ API/Interop Vendor

Consulting & Advisory - NEW (8 personas):
â”œâ”€â”€ Strategy & Implementation (3) [existing]
â”‚   â”œâ”€â”€ Healthcare Strategy Consultant
â”‚   â”œâ”€â”€ DH Implementation Consultant
â”‚   â””â”€â”€ Change Management Consultant
â”œâ”€â”€ Capital Providers (3) â† MERGED
â”‚   â”œâ”€â”€ Digital Health VC Partner
â”‚   â”œâ”€â”€ Corporate Venture Director
â”‚   â””â”€â”€ Angel Investor / Advisory
â””â”€â”€ Research & Academia (2) â† MERGED
    â”œâ”€â”€ Clinical Research PI
    â””â”€â”€ Health Services Researcher
```

---

## ğŸ“Š Updated Persona Distribution

| Category | Before | After | Change |
|----------|--------|-------|--------|
| **Digital Health** | 37 | 40 | +3 (Tech Partners merged) |
| **Consulting & Advisory** | 3 | 8 | +5 (VC + Academia merged) |
| **Enablers** | 11 | 0 | -11 (Eliminated, redistributed) |

---

## ğŸ¯ Why These Changes?

### **Tech Partners â†’ Digital Health**
- âœ… Build and deliver digital health infrastructure
- âœ… Same ecosystem and business model
- âœ… Work closely with DH startups on integrations
- âœ… Natural fit within DH category

### **VCs + Academia â†’ Consulting & Advisory**
- âœ… All provide advisory/guidance services
- âœ… VCs advise startups beyond just capital
- âœ… Academics advise on research design and evidence
- âœ… Unified "enabler/advisor" category makes sense

### **Removed Revenue/Value Focus**
- âœ… Focus on impact and evidence instead
- âœ… Pain point severity drives priority
- âœ… Adoption barriers quantified
- âœ… Clear rationale for each ranking

---

## ğŸš€ Updated Phase 2 Priorities

| Priority | Category | Personas | Evidence | Impact |
|----------|----------|----------|----------|--------|
| ğŸ”´ **P1** | Providers | 22 | **Strong**: 50% burnout, #1 barrier | **CRITICAL** |
| ğŸŸ  **P2** | Digital Health | 25 | **Strong**: 40% failure, regulatory delays | **HIGH** |
| ğŸŸ¡ **P3** | Payers | 11 | **Moderate**: STAR ratings, coverage gaps | **HIGH** |
| ğŸŸ¢ **P4** | Patients | 10 | **Strong**: 90% abandonment, adherence | **HIGH** |
| ğŸ”µ **P5** | Consulting | 8 | **Moderate**: 60-70% implementation failures | **MEDIUM** |
| âšª **P6** | Pharma | 2 | **Weak**: Nice-to-have | **LOW** |

---

## ğŸ“‹ Phase 2 Timeline

```
Month 1-2:  ğŸ”´ Providers (22 personas)       CRITICAL
Month 2-3:  ğŸŸ  Digital Health (25 personas)  HIGH (includes Tech Partners)
Month 3:    ğŸŸ¡ Payers (11 personas)          HIGH
Month 4:    ğŸŸ¢ Patients (10 personas)        HIGH
Month 4:    ğŸ”µ Consulting (8 personas)       MEDIUM (parallel with P4)
Month 5:    âšª Pharma (2 personas)           LOW
```

---

## âœ… Key Takeaways

1. **Simpler Structure**: 6 categories instead of 7 (eliminated Enablers)
2. **Natural Fit**: Tech partners belong with DH ecosystem
3. **Unified Advisory**: All advisory functions under one category
4. **Evidence-Based**: Prioritization driven by pain point data
5. **No Revenue Focus**: Impact and evidence matter more than projected value

---

**Status**: CONSOLIDATED âœ…  
**Date**: November 8, 2025  
**Next**: Launch Provider Research (P1)

---

Â© 2025 VITAL Path - All Rights Reserved

